A study into the effects of e-cig vapour on the lungs claims to have developed a new way of replicating vaping to look at how key cells that eliminate airborne irritants and infectious agents react when users inhale.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the ECigIntelligence team.
